Life science News and Research

RSS

TPP raises £9.6M to develop early-stage pre-clinical drug candidates

TPP Global Development, an innovative drug development company, announced today it has raised £9.6m which will be used to execute the Company's strategy to develop early-stage pre-clinical drug candidates.

19 May 2010

Exiqon first-quarter revenue increases 29% to record DKK 20.7M

Reported figures are for the full reporting period unless otherwise stated. Figures for the comparable reporting period last year are stated in parenthesis after realized figures. Comparative numbers in the statement of comprehensive income do not include numbers from discontinued operations. Comparative numbers in the statement of financial position include numbers from the discontinued operations.

19 May 2010

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

Tufts University's School of Arts and Sciences receives $9.5M grant to create research space

Tufts University's School of Arts and Sciences has received a $9.5 million grant to create research space that will house a Collaborative Cluster in Genome Structure and Developmental Patterning in Health and Disease.

17 May 2010

ATCC unveils new brand identity

ATCC, the premier biomaterials resource and standards organization, today proudly unveiled its new brand initiative. The fresh identity is a bold and confident logotype featuring the brand promise—THE ESSENTIALS OF LIFE SCIENCE RESEARCH. GLOBALLY DELIVERED.™ The new brand promise is an accurate reflection of ATCC's multiple offerings and global distribution network. Launch of the rebrand will bring focus to ATCC's extended capabilities as a reagents and tools company in support of life science research.

14 May 2010

Tripos releases SYBYL-X 1.1 molecular modeling suite

Tripos®, a leading provider of drug discovery informatics products and services, today announced the release and general availability of SYBYL-X Version 1.1. This new release focuses on enhancing research productivity for scientists in the pharmaceutical, agrochemical, flavors and fragrances, and related industries, featuring faster navigation, new menus and toolbars, and new ways to approach life science molecular discovery projects. Previous SYBYL versions have been the benchmark for the industry in molecular modeling, and customers using this new, next generation version have given it high marks.

13 May 2010

Pacira Pharmaceuticals receives $11.25M credit facility from GE Capital, Healthcare Financial Services

GE Capital, Healthcare Financial Services today announced it has provided an $11.25 million credit facility to Pacira Pharmaceuticals, Inc. The financing provides working capital, and facilitates advances toward regulatory approval and preparation for commercialization of Pacira's EXPAREL™ program.

12 May 2010

Jubilant Organosys reports 17.7% increase in fourth-quarter consolidated revenue

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced its financial results for Q4 & FY2010.

10 May 2010

BD Biosciences introduces new Influx Cell Sorting System

BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of the new BD Influx™ Cell Sorting System that researchers can configure with up to seven lasers to support two-way, four-way and six-way sorting, giving them flexibility to meet specific application or environmental requirements.

From BD (Becton, Dickinson and Company) 10 May 2010

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).

6 May 2010

United BioSource Corporation acquires Abt Bio-Pharma Solutions

Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. to United BioSource Corporation, a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies.

6 May 2010

Stanford University's Herzenberg Lab wins 2010 Laureate in Computerworld Honors Program

Stanford University's Herzenberg Laboratory is a 2010 Laureate in the prestigious Computerworld Honors Program. SAS, the leader in business analytics software and services, announced the award today.

30 Apr 2010

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

29 Apr 2010

European commission's FP7 programme allocated euro 6.10 billion

Europe is moving towards becoming a knowledge-based economy. Keeping in line with this objective, the European commission has instituted the Framework 7 (FP7) programme. Launched to support the re-launched Lisbon strategy, FP7 focuses on research themes rather than the framework programmes of the past. It has been designed to meet some of the persisting challenges of raising Europe to match global excellence in research, thereby benefiting the European life science funding.

27 Apr 2010

AES CHEMUNEX to distribute SDIX's RapidChek food pathogen detection systems in Europe

Strategic Diagnostics Inc., now doing business as SDIX, a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today announced it has signed a distribution agreement with AES CHEMUNEX.

27 Apr 2010

Chubb WORLDcert system simplifies process for obtaining clinical trial liability insurance documentation

A new online system from the Chubb Group of Insurance Companies will help life sciences companies deliver life-saving products to market faster by simplifying the process for obtaining clinical trial liability insurance documentation. The new system, Chubb WORLDcert, allows drug and medical device developers to quickly secure required insurance documentation for clinical trials around the globe.

27 Apr 2010

Cytovance Biologics, Selexys Pharmaceutical announce collaboration for Anti-PSGL-1 therapeutic agent

Cytovance Biologics, LLC and Selexys Pharmaceutical Corporation jointly announce an agreement and execution of a Biopharmaceutical Development and Manufacturing collaboration for their Anti-PSGL-1 therapeutic agent. This monoclonal antibody (mAb) is being developed for treatment of inflammation associated with Crohn's disease as a lead indication.

26 Apr 2010

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.

26 Apr 2010

InVivo Therapeutics CEO to be honored as one of Irish Life Science 50

InVivo Therapeutics Corporation CEO Frank Reynolds will be honored by the Irish Voice and Irish America Magazine, in collaboration with the Irish Government, as one of the 'Irish Life Science 50.' The award is the first honor to be given to influential Irish Americans for their work in the field of life sciences and is aimed to recognize "diverse accomplishments and advancements in the industry," according the Irish Voice.

23 Apr 2010

AB SCIEX to collaborate in disease studies with Samuel Lunenfeld Research Institute of Mount Sinai Hospital

AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.

22 Apr 2010

Life science News and Research

TPP raises £9.6M to develop early-stage pre-clinical drug candidates

Exiqon first-quarter revenue increases 29% to record DKK 20.7M

International Stem Cell announces strategic alliance with TAP

Tufts University's School of Arts and Sciences receives $9.5M grant to create research space

ATCC unveils new brand identity

Tripos releases SYBYL-X 1.1 molecular modeling suite

Pacira Pharmaceuticals receives $11.25M credit facility from GE Capital, Healthcare Financial Services

Jubilant Organosys reports 17.7% increase in fourth-quarter consolidated revenue

BD Biosciences introduces new Influx Cell Sorting System

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

United BioSource Corporation acquires Abt Bio-Pharma Solutions

Stanford University's Herzenberg Lab wins 2010 Laureate in Computerworld Honors Program

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

European commission's FP7 programme allocated euro 6.10 billion

AES CHEMUNEX to distribute SDIX's RapidChek food pathogen detection systems in Europe

Chubb WORLDcert system simplifies process for obtaining clinical trial liability insurance documentation

Cytovance Biologics, Selexys Pharmaceutical announce collaboration for Anti-PSGL-1 therapeutic agent

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

InVivo Therapeutics CEO to be honored as one of Irish Life Science 50

AB SCIEX to collaborate in disease studies with Samuel Lunenfeld Research Institute of Mount Sinai Hospital

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News